158 related articles for article (PubMed ID: 28394921)
21. An optimized CD4 T-cell response can control productive and latent gammaherpesvirus infection.
Sparks-Thissen RL; Braaten DC; Kreher S; Speck SH; Virgin HW
J Virol; 2004 Jul; 78(13):6827-35. PubMed ID: 15194758
[TBL] [Abstract][Full Text] [Related]
22. Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.
Ladel CH; Daugelat S; Kaufmann SH
Eur J Immunol; 1995 Feb; 25(2):377-84. PubMed ID: 7875199
[TBL] [Abstract][Full Text] [Related]
23. Persistent gamma-herpesvirus infection induces a CD4 T cell response containing functionally distinct effector populations.
Stuller KA; Cush SS; Flaño E
J Immunol; 2010 Apr; 184(7):3850-6. PubMed ID: 20208003
[TBL] [Abstract][Full Text] [Related]
24. Limited role for CD4+ T-cell help in the initial priming of Trypanosoma cruzi-specific CD8+ T cells.
Padilla A; Xu D; Martin D; Tarleton R
Infect Immun; 2007 Jan; 75(1):231-5. PubMed ID: 17043105
[TBL] [Abstract][Full Text] [Related]
25. CD4(+) T-cell dependence of primary CD8(+) T-cell response against vaccinia virus depends upon route of infection and viral dose.
Hu Z; Molloy MJ; Usherwood EJ
Cell Mol Immunol; 2016 Jan; 13(1):82-93. PubMed ID: 25544501
[TBL] [Abstract][Full Text] [Related]
26. Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection.
Stevenson PG; Belz GT; Altman JD; Doherty PC
Eur J Immunol; 1999 Apr; 29(4):1059-67. PubMed ID: 10229071
[TBL] [Abstract][Full Text] [Related]
27. Factors controlling levels of CD8+ T-cell lymphocytosis associated with murine gamma-herpesvirus infection.
Hardy CL; Flaño E; Cardin RD; Kim IJ; Nguyen P; King S; Woodland DL; Blackman MA
Viral Immunol; 2001; 14(4):391-402. PubMed ID: 11792068
[TBL] [Abstract][Full Text] [Related]
28. An optimized CD8+ T-cell response controls productive and latent gammaherpesvirus infection.
Braaten DC; Sparks-Thissen RL; Kreher S; Speck SH; Virgin HW
J Virol; 2005 Feb; 79(4):2573-83. PubMed ID: 15681457
[TBL] [Abstract][Full Text] [Related]
29. In the absence of endogenous gamma interferon, mice acutely infected with Neospora caninum succumb to a lethal immune response characterized by inactivation of peritoneal macrophages.
Nishikawa Y; Tragoolpua K; Inoue N; Makala L; Nagasawa H; Otsuka H; Mikami T
Clin Diagn Lab Immunol; 2001 Jul; 8(4):811-6. PubMed ID: 11427432
[TBL] [Abstract][Full Text] [Related]
30. Absence of cross-presenting cells in the salivary gland and viral immune evasion confine cytomegalovirus immune control to effector CD4 T cells.
Walton SM; Mandaric S; Torti N; Zimmermann A; Hengel H; Oxenius A
PLoS Pathog; 2011 Aug; 7(8):e1002214. PubMed ID: 21901102
[TBL] [Abstract][Full Text] [Related]
31. The Salivary Gland Acts as a Sink for Tissue-Resident Memory CD8(+) T Cells, Facilitating Protection from Local Cytomegalovirus Infection.
Thom JT; Weber TC; Walton SM; Torti N; Oxenius A
Cell Rep; 2015 Nov; 13(6):1125-1136. PubMed ID: 26526997
[TBL] [Abstract][Full Text] [Related]
32. Type I Interferons Direct Gammaherpesvirus Host Colonization.
Tan CS; Lawler C; May JS; Belz GT; Stevenson PG
PLoS Pathog; 2016 May; 12(5):e1005654. PubMed ID: 27223694
[TBL] [Abstract][Full Text] [Related]
33. Altered kinetics of CD4+ T cell proliferation and interferon-gamma production in the absence of CD8+ T lymphocytes in virus-infected beta2-microglobulin-deficient mice.
Vikingsson A; Pederson K; Muller D
Cell Immunol; 1996 Nov; 173(2):261-8. PubMed ID: 8912885
[TBL] [Abstract][Full Text] [Related]
34. Apparent MHC-independent stimulation of CD8+ T cells in vivo during latent murine gammaherpesvirus infection.
Coppola MA; Flaño E; Nguyen P; Hardy CL; Cardin RD; Shastri N; Woodland DL; Blackman MA
J Immunol; 1999 Aug; 163(3):1481-9. PubMed ID: 10415050
[TBL] [Abstract][Full Text] [Related]
35. K3-mediated evasion of CD8(+) T cells aids amplification of a latent gamma-herpesvirus.
Stevenson PG; May JS; Smith XG; Marques S; Adler H; Koszinowski UH; Simas JP; Efstathiou S
Nat Immunol; 2002 Aug; 3(8):733-40. PubMed ID: 12101398
[TBL] [Abstract][Full Text] [Related]
36. Cutting edge: activation of virus-specific CD4 T cells throughout γ-herpesvirus latency.
Freeman ML; Burkum CE; Lanzer KG; Jensen MK; Ahmed M; Yager EJ; Flaño E; Winslow GM; Woodland DL; Blackman MA
J Immunol; 2011 Dec; 187(12):6180-4. PubMed ID: 22079983
[TBL] [Abstract][Full Text] [Related]
37. Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts.
Wuthrich M; Filutowicz HI; Warner T; Deepe GS; Klein BS
J Exp Med; 2003 Jun; 197(11):1405-16. PubMed ID: 12782709
[TBL] [Abstract][Full Text] [Related]
38. Priming of CD8+ T cells against cytomegalovirus-encoded antigens is dominated by cross-presentation.
Busche A; Jirmo AC; Welten SP; Zischke J; Noack J; Constabel H; Gatzke AK; Keyser KA; Arens R; Behrens GM; Messerle M
J Immunol; 2013 Mar; 190(6):2767-77. PubMed ID: 23390296
[TBL] [Abstract][Full Text] [Related]
39. MHC class I immune evasion in MCMV infection.
Doom CM; Hill AB
Med Microbiol Immunol; 2008 Jun; 197(2):191-204. PubMed ID: 18330598
[TBL] [Abstract][Full Text] [Related]
40. CD8+ type 1 CD44hi CD45 RBlo T lymphocytes control intracellular Brucella abortus infection as demonstrated in major histocompatibility complex class I- and class II-deficient mice.
Oliveira SC; Splitter GA
Eur J Immunol; 1995 Sep; 25(9):2551-7. PubMed ID: 7589125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
